About [5-(3-chloro-2-piperazin-1-ylquinolin-6-yl)-1,3,4-oxadiazol-2-yl]methanamine
[5-(3-chloro-2-piperazin-1-ylquinolin-6-yl)-1,3,4-oxadiazol-2-yl]methanamine (PubChem CID 166485547) has the molecular formula C16H17ClN6O
and a molecular weight of 344.81 g/mol. Its IUPAC name is [5-(3-chloro-2-piperazin-1-ylquinolin-6-yl)-1,3,4-oxadiazol-2-yl]methanamine.
Analyze [5-(3-chloro-2-piperazin-1-ylquinolin-6-yl)-1,3,4-oxadiazol-2-yl]methanamine with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of [5-(3-chloro-2-piperazin-1-ylquinolin-6-yl)-1,3,4-oxadiazol-2-yl]methanamine?
The IUPAC name of [5-(3-chloro-2-piperazin-1-ylquinolin-6-yl)-1,3,4-oxadiazol-2-yl]methanamine (CID 166485547) is [5-(3-chloro-2-piperazin-1-ylquinolin-6-yl)-1,3,4-oxadiazol-2-yl]methanamine.
What is the SMILES notation for [5-(3-chloro-2-piperazin-1-ylquinolin-6-yl)-1,3,4-oxadiazol-2-yl]methanamine?
The canonical SMILES for [5-(3-chloro-2-piperazin-1-ylquinolin-6-yl)-1,3,4-oxadiazol-2-yl]methanamine is NCc1nnc(-c2ccc3nc(N4CCNCC4)c(Cl)cc3c2)o1.
What is the InChIKey of [5-(3-chloro-2-piperazin-1-ylquinolin-6-yl)-1,3,4-oxadiazol-2-yl]methanamine?
The InChIKey is FZXBNLDBRTXTGJ-UHFFFAOYSA-N. The full InChI is InChI=1S/C16H17ClN6O/c17-12-8-11-7-10(16-22-21-14(9-18)24-16)1-2-13(11)20-15(12)23-5-3-19-4-6-23/h1-2,7-8,19H,3-6,9,18H2.
What are the key properties of [5-(3-chloro-2-piperazin-1-ylquinolin-6-yl)-1,3,4-oxadiazol-2-yl]methanamine?
[5-(3-chloro-2-piperazin-1-ylquinolin-6-yl)-1,3,4-oxadiazol-2-yl]methanamine has a molecular weight of 344.81 g/mol, XLogP of 1.81, 3 rotatable bonds, 2 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for [5-(3-chloro-2-piperazin-1-ylquinolin-6-yl)-1,3,4-oxadiazol-2-yl]methanamine is sourced from PubChem (CID 166485547), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).